Meadowhawk Biolabs, Inc.
Peter Glick is an accomplished entrepreneur and executive with extensive experience in the biopharmaceutical and biotechnology sectors. Currently serving as Chairman and Co-Founder of Meadowhawk Biolabs, Inc. and Chairman of NanoImaging Services, Glick has demonstrated a commitment to enhancing drug discovery and development processes. Previous leadership roles include Executive Chairman at Dynex Technologies, Chairman & Co-Founder of Agilux Laboratories, and General Partner at Ampersand Capital Partners, among others. Glick’s educational background includes a Master of Science in Management from the MIT Sloan School of Management and a Bachelor of Science in Finance from The Wharton School.
This person is not in any teams
Meadowhawk Biolabs, Inc.
Meadowhawk biolabs is a CRO that was created to make a difference for our pharmaceutical and biotech clients in drug discovery and development. Our curiosity, unwillingness to accept the status quo and unflagging commitment and alignment to our values drives us to partner with our clients to bring new treatments and therapeutics faster to patients.